F UNCTIONAL impairment, a common occurrence in aging, is generally measured as any difficulty that interferes with or limits functioning in one or more major life activities, including basic and instrumental activities of daily living (ADL, IADL) (1) (2) (3) . Research suggests that physiologic processes such as the production of proinflammatory complexes may underlie functional impairment. Several studies have described a relationship between markers such as C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-a (TNF-a) and measures of functional impairment, physical decline, and walking speed, in older populations (4-7). Ferrucci and colleagues (8) suggest that overproduction of cytokines and maintenance of the inflammatory state over a long period may lead to physical degeneration in elderly populations.
It has also been reported that persistent infections may act as proinflammatory agents and are involved as stimuli that underlie and sustain the process of chronic inflammation (9) (10) (11) . For example, one study has shown that asymptomatic chronic cytomegalovirus (CMV) infection is linked to greater frailty in older women and that the relationship is enhanced by IL-6 (9) . Chronic latent infections, such as CMV and herpes simplex virus-1 (HSV-1), have the potential to induce chronic inflammatory states because they undergo periodic reactivation, thereby triggering subsequent inflammatory responses (10, 12) . CMV and HSV-1 infections often pass undiagnosed because of their asymptomatic properties, and remain persistent in the system for life, with an increasing risk of reactivation during old age and in response to stress (13) (14) (15) (16) . More recently, immunological studies have suggested that aging populations infected with CMV experience large clonal expansion of CD8þ effector T cells resulting in a reduction in the ''immunological space'' and a loss of response to foreign antigens other than CMV (17) . Persistent CMV has been called one of the ''driving forces'' behind age-related alterations among T cells in elderly persons (18) (19) (20) . The immunological effects of persistent CMV and other herpesviruses, such as HSV, may influence chronic conditions associated with aging. In addition to frailty, infection with CMV has been linked to cardiovascular disease, cognitive outcomes, and Alzheimer's disease (11, (21) (22) (23) .
Both CMV and HSV-1 are common worldwide and are found in .83% of individuals 60 years old and older in the United States (24, 25) . Factors such as age, gender, race/ ethnicity, and education are associated with HSV-1 and CMV seropositivity (24, 25) . Ethnic differences in infection have been found among persons 60-69 years old, with 95% of Mexican Americans having antibody to HSV-1 compared to 83% in non-Latino white populations (24) . Similar prevalence estimates as well as race/ethnic disparities have been reported for CMV in the United States (25) . Among individuals who are seropositive for HSV-1 or CMV, factors that may lead to higher levels of antibodies and possibly clinical reaction include stress, organ transplant, and immunosuppression (10, (26) (27) (28) . Collectively, these data suggest important roles for persistent infection and resultant chronic inflammation in the development of older age functional impairment, especially among minority populations such as Mexican Americans.
To date, CMV has been assessed in relation to a composite measure of frailty among a group of predominantly white women (9) . There are no data, to our knowledge, that have assessed the influence of CMV on measures of ADL, IADL, and walking pace. In this study, we assess whether persistent antibodies to CMV and HSV-1 and CRP levels are associated with functional impairment in older Latino adults.
METHODS

Study Population
The participants were enrolled in the Sacramento Area Latino Study on Aging (SALSA) study, which is a large, ongoing prospective cohort study of predominantly Mexican Americans living in the community, who were 60-101 years old at baseline in 1998-1999. More detailed information on sampling frame, recruitment procedures, and interviews are published elsewhere (29) . At the end of baseline, 1789 people were enrolled in the study. The results of blood tests for infection and inflammatory markers were available for 1559 participants of which 1507 had measurements of ADL impairment, 1261 had measurements of IADL impairment, and 1444 had measurements of walking pace. Therefore, our analyses used these subgroups with available data regarding infection, inflammation, ADL, IADL, and walking pace impairment.
Study Design
Baseline data collection began in 1998-1999. Each participant answered questions regarding sociodemographic factors, lifestyle factors, acculturation, and medical diagnoses. Blood was drawn for measurement and analyses of antibodies, inflammatory markers, lipids, glucose, and insulin on the same day as the interview. Additionally, participants completed several physical performance tests.
Laboratory Analyses
Baseline frozen serum samples were analyzed for both CMV and HSV-1 infections and CRP levels. A standard commercial, highly sensitive, enzyme-linked immunosorbent assay (ELISA) kit was used for detecting type-specific immunoglobulin G (IgG) antibody responses to CMV and HSV-1 (Wampole Laboratories, Princeton, NJ). Antibody levels were measured by optical density units. The sensitivity and specificity of the assay for HSV-1 are reported to be 97.1% and 96.8%, respectively; for CMV, the sensitivity and specificity are reported to be 99% and 94%, respectively. Serum samples were also used to analyze levels of CRP by means of the CRP Ultra Wide Range Reagent Kit latex-enhanced immunoassay (Equal Diagnostics, Exton, PA).
Functional Measures
ADL and IADL impairment was measured based on selfreported functional status (2, 30) . The ADL measurement consisted of seven items, and was used to measure ability to perform activities such as walking across a small room, bathing, eating, and using the toilet (1). The IADL measurement consisted of 15 items and was used to measure ability to perform activities as described earlier (3) . Both the ADL and IADL measurements used a standard Likert-type scale (30) . Additionally, a self-reported measure of walking pace was used in which participants reported their usual walking pace outdoors, using a multiple-category scale consisting of, ''Never walks outdoors,'' ''Unable to walk,'' ''Easy, casual,'' ''Normal, average,'' ''Brisk pace,'' or ''Very brisk/ striding'' (31).
Covariates
Age and gender of each participant were recorded. Birthplace was measured by asking participants for their country of birth. Self-reported gross household income was measured based on last month's income, and educational attainment by asking the total number of school years completed. A modified Charlson comorbidity index was created to control for the effect of chronic health conditions on functional impairment. Points were assigned for having myocardial infarction, congestive heart failure, stroke, dementia, liver disease, diabetes, renal disease, any malignancy, and leukemia or lymphoma and then summed to generate a comorbidity score for each participant. The following conditions were not included in the modified index due to lack of data: peripheral vascular disease, cerebrovascular disease, chronic pulmonary disease, connective tissue disease, ulcer disease, hemiplegia, diabetes with end organ damage, and acquired immunodeficiency syndrome (AIDS). In addition, it was not possible to differentiate severity of liver disease and renal disease or differentiate between leukemia and malignant lymphomas. Body mass index (BMI) at baseline was calculated using measured height and weight. Smoking status was measured in packyears.
Statistical Analyses
Statistical analyses were performed using SAS (version 9.1; SAS Institute, Cary, NC). Baseline demographic analysis was carried out using t tests for difference in means and chi-squared tests for differences in proportions or for trends among demographic groupings. All significance tests were two-tailed, and p values , .05 were considered statistically significant.
Each of the 7 ADL and 15 IADL outcome measures were transformed from the Likert-type scale into a binary variable. A response of ''no difficulty'' in completing an activity was defined as having no difficulty and assigned a score of 0. Responses of ''some difficulty,'' ''a lot of difficulty,'' or ''only with help from a person or equipment'' were defined as having difficulty and assigned a score of 1. A summary score was created as a continuous variable for ADL and IADL (range 0-7 and 0-15, respectively) and then transformed into a binary variable. The final binary ADL variable was dichotomized as: (1) difficulty in one or more activities or (2) no difficulty in activities. The final binary IADL variable was dichotomized as: (1) difficulty in three or more activities, or (2) difficulty in two or fewer activities. This method of dichotomizing ADL and IADL has been used elsewhere (32) . CMV and HSV-1 antibody titer and CRP level were assessed as continuous variables and in tertiles to generate odds ratios. Because continuous CRP levels were not normally distributed, values were transformed using natural logarithm. Lastly, outdoor walking pace was transformed into a binary variable in which a response of ''Easy, casual'' or ''Unable to walk'' was defined as having a walking pace below average and a response of ''Normal, average,'' ''Brisk pace,'' or ''Very brisk/striding'' was defined as having a walking pace at or above average. Participants who responded, ''Never walks outdoors'' were omitted (N ¼ 51).
Binary logistic regression was conducted to assess the relationship between each predictor variable (CMV, HSV-1, and CRP) and each outcome of interest (ADL, IADL, and walking pace). First, unadjusted associations between each exposure and outcome were assessed using odds ratios and 95% confidence intervals (CI). Variables that were significantly associated with both the main predictors and outcomes of interest in bivariate analyses and were not hypothesized to be mediators were included as potential confounders in the models. Factors such as age, gender, socioeconomic status, chronic health conditions, BMI, birthplace, and smoking status were examined because they have been shown to be potential confounders of either the exposures or functional impairment outcomes (4, 6, 8, 9, 25, 32, 33) .
RESULTS
Comparisons of demographic and clinical characteristics by ADL, IADL, and walking pace impairment are shown in Table 1 . Twelve percent of participants reported having difficulty completing one or more ADL, and for IADL, 42% reported having difficulty completing three or more activities. Increased age, female gender, lower monthly income, and lower educational attainment were significantly associated with having difficulty in ADL and IADL. Twenty-seven percent of participants reported below average walking pace. Increased age, female gender, birthplace, lower monthly income, and lower educational attainment were significantly associated with below average walking pace.
Clinical characteristics such as BMI, smoking status, and total chronic health conditions (modified Charlson comorbidity index) were also assessed in relation to ADL and IADL difficulties (see Table 1 ). There was no significant difference in BMI by ADL difficulties. In contrast, the mean BMI among participants with IADL difficulties was significantly higher than that among participants without difficulties. Participants with difficulties in ADL and IADL and below average walking pace had significantly more chronic health conditions.
Of the 1559 participants, approximately 96% were considered CMV seropositive (i.e., having signs of prior exposure) by the ELISA testing cut points, and 98% were found seropositive for HSV-1. There were only small differences in seropositivity by ADL and IADL impairment. CMV and HSV-1 antibody titers were significantly higher among those with ADL difficulties (p ¼ .0003) and (p ¼ .0078), respectively (see Figure 1) . CMV was significantly higher among those with IADL difficulties (p ¼ .0083) and those with below average walking pace (p ¼ .0067) (see Figure 1 ). Mean CRP levels were significantly higher among those with ADL and IADL difficulty (p ¼ .0042 and p , .0001, respectively) (see Figure 1) . Mean CRP levels were also significantly higher among those with below average walking pace versus above average walking pace (p , .0001). CMV was significantly correlated with CRP (r ¼ 0.1156, p , .0001), but there was no significant correlation between HSV and CRP or between HSV and CMV.
Association Between Infection, Inflammation, and ADL Difficulty Table 2 shows the associations between CMV and HSV-1 infection and CRP in relation to ADL impairment in unadjusted and adjusted models. Figure 2 shows that, after adjustment for age and gender, a statistically significant association was observed between ADL difficulty and the highest tertile of CMV antibody titer. For CMV, statistical significance was lost in the fully adjusted model, and the odds ratio was reduced by 27% compared to the unadjusted model, but the graded relationship between increasing CMV levels and difficulty was still evident. A statistically significant relationship between the middle and highest level of CRP and ADL difficulty was evident before and after control for age and gender (Table 2 ), but the relationship was no longer significant after controlling for age, gender, education, income, and total number of chronic health conditions ( Figure 3 ). Increasing HSV-1 levels were not associated with ADL impairment.
Association Between Infection, Inflammation, and IADL Difficulty
In the unadjusted analysis, there was a significant association between being in the highest tertile of CMV antibody titer and IADL difficulty (see Table 3 ). After full adjustment, there was no association between being in the highest tertile of CMV and IADL difficulty. HSV-1 levels were not associated with IADL difficulty. There were significantly higher odds of IADL difficulty among participants in the middle and high CRP tertiles (see Table 3 ). After full adjustment, only high levels of CRP remained significantly associated with difficulty completing IADL.
Association Between Infection, Inflammation, and Walking Pace
In the unadjusted analysis, higher CMV antibody levels and higher CRP levels were significantly associated with a below average outdoor walking pace (see Table 4 ). After adjusting for covariates, the only significant relationship that remained was between high CRP level and below average walking pace.
DISCUSSION
This study of older Latinos suggests a consistent crosssectional association between high CRP levels and three self-reported measures of functional impairment. There was also a significant graded association with CMV and ADL difficulties, but after adjustment for comorbidities the odds ratio was reduced and no longer significant. HSV-1, in contrast, showed no evidence of a relationship with ADL, IADL, or walking pace.
Only one other study at this time, by Schmaltz and colleagues (9) , has looked at the association of persistent infection and a functional measure in older populations. They used a dichotomous measure of CMV infection status (positive or negative) and a composite measure of frailty as an outcome (9) . In our study, however, continuous measures of both CMV and HSV-1 infection (antibody responses) were used because these infections were found to be highly prevalent in the study population, and it is likely that an increased antibody level may be a better reflection of the intensity of exposure and immune response to these infections over the life course (11, 19) . Moreover, the study by Schmaltz and colleagues focused solely on white elderly women, whereas this study analyzed data from a large population of men and women, primarily of Mexican American or Mexican descent. Given the differences in demographic and infection measures between these two studies, we cannot directly compare our results to those of Schmaltz and colleagues (9) . However, our results regarding the relationship between CMV specifically and ADL impairment are further evidence supporting a potential relationship between this persistent infection and measures of physical functioning.
A major strength of this study is that, to our knowledge, this is the first study to examine collectively the relationships among multiple markers of persistent infection, an infection-related inflammatory marker, and three validated measures of physical functioning. In addition, our statistical models controlled for many known risk factors for functional impairment, such as age, comorbid health conditions, and BMI (33, 34) . In addition, all of the laboratory testing of the biological markers was conducted using validated test kits with high sensitivity and specificity and the use of positive and negative controls. Although a graded association between CMV and ADL impairment was observed after full adjustment for covariates such as health conditions, income, and BMI, the effect Odds ratios (OR) and 95% confidence intervals for ADL difficulty according to low, middle, and high tertiles of (ln) natural log CRP levels. The OR values compare the middle and high antibody tertiles to the lowest tertile as the referent category. *Significant at p , .05.
estimates were no longer statistically significant. Given that control for factors such as chronic health conditions reduces the relationship between CMV and ADL impairment, it is possible that chronic health conditions associated with aging may concurrently lead to higher levels of CMV antibodies and functional impairments in aging populations. Both CMV and HSV-1 have been implicated as initiators of chronic inflammation-related conditions including cardiovascular disease and Alzheimer's disease (22, 23) . A longitudinal study is needed to more clearly explicate the temporal relationships among CMV antibody levels and physical decline. The reactivation of persistent CMV infection has been associated with activation of inflammatory molecules, such as increased levels of CRP and IL-6 (10). However, in this cross-sectional analysis, CRP levels were weakly correlated with CMV. It may be worthwhile, however, to further explore the relationship between CMV infection and cytokines such as IL-6, in relation to ADL and IADL impairment.
Our earlier research in the SALSA population showed a significant relationship between CMV antibody levels and cognitive decline over a 5-year period, but no relationship with HSV-1 (11) . Similarly, there were no associations between HSV-1 IgG antibody levels and measures of functional impairment. It is possible that HSV-1 infection may still be related to decline in functioning over time. However, the specificity of the association with CMV in our study and the consistency with other researcher's findings (9) suggests that CMV, in particular, may be an important indicator of physical functioning. Several studies have observed a heightened IgG antibody response to CMV as well as other herpesviruses in older compared to younger persons (13) (14) (15) . For example, a recent study by Stowe and colleagues (35) reported a 4 unit higher average serum CMV IgG antibody level among persons 66 years old or older compared to persons 25-55 years old (p , .0001) (35) . Stowe and colleagues also identified detectable CMV DNA in the urine of the old individuals but did not identify CMV DNA in the blood (35) . They suggest that the presence of heightened serum CMV antibody levels in combination with CMV DNA in urine only is a sign of frequent CMV reactivation that occurs at subclinical levels in old persons (35) . Cell-mediated control is important for keeping persistent viral infections such as HSV-1 and CMV from reactivating (16, 36, 37) . Changes in cell-mediated immune parameters often occurs with aging (19, 38) . For these reasons, it is likely that higher IgG antibody titers to CMV among infected aging populations is correlated with subclinical reactivation.
It is unclear how CMV might directly influence physical functioning, but indirect pathways may include changes in cellular components of immune function. Recently, several researchers have identified CMV as an important component of an immune risk phenotype that is associated with immunosenescence, inflammation, and several chronic health conditions observed with aging (19) . CMV infection occurs early in life, and CD8þCD28À cells are generated to maintain control over persistent CMV infection over the life course (39). Wikby and colleagues (39) recently demonstrated that CMV induces changes in the CD4 T-cell compartment that are different than what usually occurs during aging and emphasized the importance of considering CMV status when examining immunosenescent changes in the elderly population. Longitudinal data assessing the interaction between CMV, specific cellular markers, and inflammation in relation to physical decline is necessary.
ADL, IADL, and walking pace impairment were found to be significantly associated with increasing levels of CRP. These results are consistent with those from previous studies that have examined various markers of inflammation and measures of physical functioning in elderly populations (4, 8, 40) . High CRP levels have been associated with loss of muscle strength and mass in older men and women and have been found to be an important factor in cardiovascular conditions, type 2 diabetes, and metabolic syndrome (41, 42) . Inflammation and health conditions, in turn, impact physical function and functional impairment. Nonetheless, the relationship between CRP and physical functioning in our study was independent of comorbid conditions, such as diabetes and cardiovascular conditions, and BMI, suggesting that CRP influences physical functioning via other pathophysiological processes.
A few limitations must be considered. First, this is a cross-sectional study; therefore, caution should be taken in making temporal inferences. However, CMV infection often occurs in childhood, antibody levels to persistent herpesvirus infections are generally stable over time, and CRP is known to increase in response to infection, suggesting that CMV antibody response would biologically precede CRP increases (25, 43) . Second, we used a modified version of the Charlson comorbidity index because some of the conditions that are generally applied to this index were not available for our study population. However, the variables that we did include in the modified index are known to be important factors associated with increases in CRP and possibly CMV, such as myocardial infarction and liver disease. In addition, the application of the Charlson comorbidity index in this population may be overly stringent because our population is a community-dwelling sample and the index is generally applied to patients who are already ill in the clinical setting.
It is also possible that Mexican Americans possess unique characteristics that impact their exposure and response to CMV infection (25) as well as functional decline. For example, factors such as country of birth, age at migration, and duration since migration to the United States might influence both exposure to CMV infection and physical activities. CMV was highly prevalent among our study sample, and birthplace was associated with walking pace, suggesting potential cultural differences in general walking speed by place of birth. Therefore, the results of this study may be specific to individuals with characteristics similar to the SALSA study population.
Conclusion
This study provides further evidence that CRP and possibly infection with CMV may have important roles in the aging process, and more specifically, functional impairment. Further longitudinal studies examining the influence of CRP and persistent infections are needed to more fully elucidate the biological roles and underlying mechanisms associated with physical decline and the aging process. The clinical implications of this study indicate that preventive efforts targeting inflammation and possibly persistent infection may help enhance physical functioning among aging Latinos.
